Imunon
IMNN
23 hedge funds and large institutions have $2.66M invested in Imunon in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 16 closing their positions.
117% more call options, than puts
Call options by funds: $219K | Put options by funds: $101K
0.65% more ownership
Funds ownership: 0.05% → 0.7% (+0.65%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
36% less capital invested
Capital invested by funds: $4.14M → $2.66M (-$1.49M)
38% less funds holding
Funds holding: 37 → 23 (-14)
81% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$184K |
| 2 |
Renaissance Technologies
New York
|
+$116K |
| 3 |
Two Sigma Investments
New York
|
+$90.8K |
| 4 |
Two Sigma Advisers
New York
|
+$75.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$30.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$145K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$72K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$72K |
| 4 |
VF
Virtu Financial
New York
|
-$55K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$35K |
IMNN Hedge Fund Activity: Q1 2022 in Review
23 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2022, worth a combined $2.66M — down 36% from $4.14M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of IMNN and 3 opened new positions — a net loss of 13 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Citadel Advisors, adding an estimated $184K. The largest seller was Vanguard Group, cutting an estimated $145K.
- 23 institutional investors held Imunon (IMNN) as of Q1 2022, down from 37 in Q4 2021.
- Funds reported $2.66M of Imunon stock for Q1 2022, down 36% quarter-over-quarter.
- 3 funds opened new Imunon positions in Q1 2022 and 16 closed out, a net change of -13 holders.
- The largest Imunon buyer in Q1 2022 was Citadel Advisors, an estimated $184K added.
- The largest Imunon seller in Q1 2022 was Vanguard Group, an estimated $145K sold.
Based on aggregated 13F filings for Q1 2022.